Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $551.55 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $174.18 | 8 | $0 (2022) |
| Lilly USA, LLC | $131.98 | 1 | $0 (2017) |
| Aralez Pharmaceuticals US Inc. | $123.33 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $55.70 | 4 | $0 (2019) |
| Foundation Medicine, Inc. | $29.10 | 1 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $19.23 | 1 | $0 (2017) |
| PORTOLA PHARMACEUTICALS, LLC | $18.03 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $23.20 | 1 | Janssen Pharmaceuticals, Inc ($23.20) |
| 2020 | $32.12 | 2 | PORTOLA PHARMACEUTICALS, LLC ($18.03) |
| 2019 | $136.25 | 7 | Janssen Pharmaceuticals, Inc ($63.82) |
| 2018 | $54.85 | 2 | Janssen Pharmaceuticals, Inc ($54.85) |
| 2017 | $305.13 | 5 | Lilly USA, LLC ($131.98) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/08/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/08/2020 | PORTOLA PHARMACEUTICALS, LLC | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $18.03 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 06/04/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/31/2019 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/30/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $39.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/14/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/07/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $131.98 | General |
| Category: Diabetes | ||||||
| 07/19/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.23 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/19/2017 | Aralez Pharmaceuticals US Inc. | YOSPRALA (Drug) | Food and Beverage | In-kind items and services | $123.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/17/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 32 | 45 | $5,935 | $2,920 |
| 2022 | 7 | 483 | 859 | $137,417 | $62,410 |
| 2021 | 8 | 530 | 926 | $155,637 | $71,134 |
| 2020 | 9 | 586 | 957 | $167,805 | $77,419 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 45 | $5,935 | $2,920 | 49.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 134 | 283 | $53,736 | $24,427 | 45.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 151 | 340 | $44,843 | $20,464 | 45.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 111 | 113 | $14,995 | $6,861 | 45.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 32 | $11,956 | $5,334 | 44.6% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $4,762 | $2,072 | 43.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 51 | $3,670 | $1,688 | 46.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 26 | 26 | $3,456 | $1,564 | 45.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 145 | 347 | $65,888 | $30,587 | 46.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 143 | 318 | $41,941 | $18,868 | 45.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 124 | 130 | $17,251 | $7,877 | 45.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 31 | 32 | $11,956 | $5,119 | 42.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 23 | 23 | $7,823 | $3,629 | 46.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 32 | 35 | $4,653 | $2,232 | 48.0% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 18 | 18 | $4,470 | $2,056 | 46.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 23 | $1,655 | $765.62 | 46.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 179 | 377 | $71,585 | $32,918 | 46.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 140 | 302 | $39,831 | $18,432 | 46.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 49 | 50 | $18,681 | $8,398 | 45.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 111 | 115 | $15,261 | $7,092 | 46.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 27 | 28 | $9,524 | $4,469 | 46.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 36 | 36 | $4,785 | $2,288 | 47.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 21 | 21 | $4,121 | $1,925 | 46.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 11 | $2,796 | $1,318 | 47.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 12 | 17 | $1,223 | $579.09 | 47.3% |
About Dr. Leonard Khrizman, M.D
Dr. Leonard Khrizman, M.D is a Internal Medicine healthcare provider based in Meadowbrook, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1073721999.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonard Khrizman, M.D has received a total of $551.55 in payments from pharmaceutical and medical device companies, with $23.20 received in 2022. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($551.55).
As a Medicare-enrolled provider, Khrizman has provided services to 1,631 Medicare beneficiaries, totaling 2,787 services with total Medicare billing of $213,882. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Meadowbrook, PA
- Active Since 05/21/2007
- Last Updated 03/17/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073721999
Products in Payments
- XARELTO (Drug) $174.18
- TRULICITY (Drug) $131.98
- YOSPRALA (Drug) $123.33
- BRILINTA (Drug) $55.70
- FOUNDATIONONE (Device) $29.10
- LifeVest (Device) $19.23
- ANDEXXA (Biological) $18.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Meadowbrook
David Litt, Md, MD
Internal Medicine — Payments: $3,821
John Butler, Md, MD
Internal Medicine — Payments: $2,871
Dominick Galluzzo, Md, MD
Internal Medicine — Payments: $2,072
Joseph Viknevich, M.d, M.D
Internal Medicine — Payments: $453.22
Dr. Babak Pirouz, Md, MD
Internal Medicine — Payments: $314.45
Maureen Armstrong, Do, DO
Internal Medicine — Payments: $121.36